Bielpharma has filed financial statements for 5 reporting years in the Polish National Court Register (KRS 0000857092), covering 2020–2024. The dashboard below shows the income statement, balance sheet, profitability ratios, valuation indicators and a multi-year comparison against the company's industry benchmark.

Headline figures for the most recent reported year (2024): net revenue 20,891 PLN, net profit -11,854 PLN, total assets 92,216 PLN and equity -273,308 PLN. Use the chart toolbar to switch between absolute amounts and indexed series, or to jump straight into the per-year sprawozdanie finansowe.

Derived metrics include ROE, ROA, net and operating margin, the current ratio and the cash ratio, debt-to-equity and asset turnover. Each ratio is plotted alongside the median for Bielpharma's PKD activity class, so reading whether the company is above or below the industry takes one glance instead of a side-by-side calculation.